Figure 8.

Greater reversal of remodeling after autologous cardiopoietic stem cell therapy at 6‐month follow‐up (C‐CURE trial). A, Changes in left ventricular ejection fraction (LVEF) for each individual patient. Control group (black) includes patients that received standard of care alone. Cell therapy group (gray) includes patients that received standard of care plus cardiopoietic stem cells. B, Median values for LVEF prior to and 6‐months following treatment. C, Changes in left ventricular end‐diastolic (ED) and end‐systolic (ES) volumes. Reproduced with permission from Bartunek et al, JACC, 2013.¹²